Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 72426 - 72450 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	PSMD9	5715	upregulated	Silicon Dioxide results in increased expression of PSMD9 mRNA	12q24.31	A24196
Silicon dioxide	Approved	PSME1	5720	downregulated	Silicon Dioxide analog results in decreased expression of PSME1 mRNA	14q12	A24195
Silicon dioxide	Approved	PSME4	23198	upregulated	Silicon Dioxide results in increased expression of PSME4 mRNA	2p16.2	A24196
Silicon dioxide	Approved	PSMG3	84262	upregulated	Silicon Dioxide analog results in increased expression of PSMG3 mRNA	7p22.3	A24195
Silicon dioxide	Approved	PSMG3-AS1	114796	downregulated	Silicon Dioxide analog results in decreased expression of PSMG3-AS1 mRNA	7p22.3	A24195
Silicon dioxide	Approved	PSORS1C1	170679	downregulated	Silicon Dioxide analog results in decreased expression of PSORS1C1 mRNA	6p21.33	A24195
Silicon dioxide	Approved	PSORS1C1	170679	upregulated	Silicon Dioxide results in increased expression of PSORS1C1 mRNA	6p21.33	A24196
Silicon dioxide	Approved	PSPC1	55269	upregulated	Silicon Dioxide results in increased expression of PSPC1 mRNA	13q12.11	A24196
Silicon dioxide	Approved	PSPH	5723	downregulated	Silicon Dioxide analog results in decreased expression of PSPH mRNA	7p11.2	A24194
Silicon dioxide	Approved	PSPH	5723	downregulated	Silicon Dioxide results in decreased expression of PSPH mRNA	7p11.2	A24196
Silicon dioxide	Approved	PTAFR	5724	upregulated	Silicon Dioxide analog results in increased expression of PTAFR mRNA	1p35.3	A24195
Silicon dioxide	Approved	PTAFR	5724	upregulated	Silicon Dioxide results in increased expression of PTAFR mRNA	1p35.3	A24196
Silicon dioxide	Approved	PTCD2	79810	downregulated	Silicon Dioxide results in decreased expression of PTCD2 mRNA	5q13.2	A24196
Silicon dioxide	Approved	PTCH1	5727	downregulated	Silicon Dioxide analog results in decreased expression of PTCH1 mRNA	9q22.32	A24195
Silicon dioxide	Approved	PTCH2	8643	downregulated	Silicon Dioxide analog results in decreased expression of PTCH2 mRNA	1p34.1	A24195
Silicon dioxide	Approved	PTCHD1	139411	upregulated	Silicon Dioxide analog results in increased expression of PTCHD1 mRNA	Xp22.11	A24194
Silicon dioxide	Approved	PTGDR2	11251	downregulated	Silicon Dioxide analog results in decreased expression of PTGDR2 mRNA	11q12.2	A24195
Silicon dioxide	Approved	PTGER1	5731	upregulated	Silicon Dioxide analog results in increased expression of PTGER1 mRNA	19p13.1	A24195
Silicon dioxide	Approved	PTGER2	5732	downregulated	Silicon Dioxide analog results in decreased expression of PTGER2 mRNA	14q22.1	A24195
Silicon dioxide	Approved	PTGER4	5734	upregulated	Silicon Dioxide results in increased expression of PTGER4 mRNA	5p13.1	A24196
Silicon dioxide	Approved	PTGES	9536	upregulated	Silicon Dioxide analog results in increased expression of PTGES mRNA	9q34.11	A24195
Silicon dioxide	Approved	PTGIR	5739	upregulated	Silicon Dioxide analog results in increased expression of PTGIR mRNA	19q13.32	A24195
Silicon dioxide	Approved	PTGR1	22949	downregulated	Silicon Dioxide analog results in decreased expression of PTGR1 mRNA	9q31.3	A24195
Silicon dioxide	Approved	PTGR2	145482	downregulated	Silicon Dioxide analog results in decreased expression of PTGR2 mRNA	14q24.3	A24195
Silicon dioxide	Approved	PTGS1	5742	upregulated	Silicon Dioxide analog results in increased expression of PTGS1 mRNA	9q33.2	A24195

Displaying entries 72426 - 72450 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability